Jyong Biotech MENS
NASDAQ MENS
$2.18 +0.15 (+7.39%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Other Accumulated Expenses (2024 - 2025)

Updated

Jyong Biotech (MENS) recorded Other Accumulated Expenses of $3.45 million in the quarter ended Dec 31, 2025, up 4.8% from $3.29 million a year earlier.

Analysis

Jyong Biotech (MENS) Other Accumulated Expenses (2024 - 2025) Analysis & Trends

  • Across earlier years, Other Accumulated Expenses came in at $3.29 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Jyong Biotech 165.74 Mn 165.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.45 Mn
Jun 30, 2025 3.37 Mn
Dec 31, 2024 3.29 Mn
API Access

Jyong Biotech Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MENS&period=max&api_key=YOUR_API_KEY